Jay Hancock, Senior Correspondent, joined KHN in 2012 from The Baltimore Sun, where he wrote a column on business and finance. Previously he covered the State Department and the economics beat for The Sun and health care for The Virginian-Pilot of Norfolk and the Daily Press of Newport News. He has a bachelor’s degree from Colgate University and a master’s in journalism from Northwestern University.
Jay Hancock
From this contributor
By
Jay Hancock, Sydney Lupkin, Elizabeth Lucas, Kaiser Health News
21 April 2017
5 min read
Health companies gave generously to President Trump’s inauguration
Facing acute risks to their businesses from Washington policymakers, health companies spent more than $2 million to buy access to the incoming Trump administration via candlelight dinners, black-tie balls and other inauguration events.
Health companies gave generously to President Trump’s inauguration
By
Jay Hancock, Sydney Lupkin, Elizabeth Lucas, Kaiser Health News
21 April 2017 | 5 min read
Explore more from The Transmitter
Cerebellum responds to language like cortical areas
One of four language-responsive cerebellar regions may encode meaningful information, much like the cortical language network in the left hemisphere, according to a new study.
Cerebellum responds to language like cortical areas
One of four language-responsive cerebellar regions may encode meaningful information, much like the cortical language network in the left hemisphere, according to a new study.
By
Natalia Mesa
6 February 2026 | 4 min read
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
By
Lauren Schneider
4 February 2026 | 7 min read
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
By
Claudia López Lloreda
3 February 2026 | 4 min read